<DOC>
	<DOCNO>NCT00079924</DOCNO>
	<brief_summary>Effects Teriparatide Postmenopausal Women Previously Treated Alendronate Raloxifene .</brief_summary>
	<brief_title>Effects Teriparatide Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Postmenopausal woman age least 50 year A previous clinical diagnosis osteoporosis At high risk fracture Current therapy least 18 month prior study entry either raloxifene HCl alendronate Na History metabolic bone disease osteoporosis History malignant neoplasm within last 5 year except superficial basal cell carcinoma squamous cell carcinoma</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>